Nucleocapsid Antigenemia in Patients Receiving Anti-CD20 Therapy With Protracted COVID-19.
SARS-CoV-2
antigenemia
diagnostics
immunocompromised
Journal
Open forum infectious diseases
ISSN: 2328-8957
Titre abrégé: Open Forum Infect Dis
Pays: United States
ID NLM: 101637045
Informations de publication
Date de publication:
Aug 2022
Aug 2022
Historique:
received:
12
06
2022
accepted:
15
08
2022
entrez:
31
8
2022
pubmed:
1
9
2022
medline:
1
9
2022
Statut:
epublish
Résumé
Immunocompromised patients with prolonged coronavirus disease 2019 symptoms present diagnostic and therapeutic challenges. We measured viral nucleocapsid antigenemia in 3 patients treated with anti-CD20 immunotherapy who acquired severe acute respiratory syndrome coronavirus 2 infection and experienced protracted symptoms. Our results support nucleocapsid antigenemia as a marker of persistent infection and therapeutic response.
Identifiants
pubmed: 36043176
doi: 10.1093/ofid/ofac419
pii: ofac419
pmc: PMC9416058
doi:
Types de publication
Journal Article
Langues
eng
Pagination
ofac419Subventions
Organisme : NIGMS NIH HHS
ID : T32 GM008169
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM142617
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL069769
Pays : United States
Organisme : NIBIB NIH HHS
ID : U54 EB027690
Pays : United States
Informations de copyright
© The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Déclaration de conflit d'intérêts
Potential conflicts of interest. The authors: no reported conflicts of interest. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
Références
N Engl J Med. 2020 Dec 24;383(26):2586-2588
pubmed: 33259154
J Virol Methods. 2022 Apr;302:114469
pubmed: 35051445
J Infect Dis. 2021 Mar 29;223(6):945-956
pubmed: 33325510
Blood. 2020 Nov 12;136(20):2290-2295
pubmed: 32959052
Clin Chem. 2021 Dec 30;68(1):240-248
pubmed: 34358289
J Infect Dis. 2022 Jul 25;:
pubmed: 35877413
Sci Rep. 2022 May 18;12(1):8273
pubmed: 35585163
Clin Infect Dis. 2022 May 30;74(10):1786-1794
pubmed: 34383032
Cell. 2020 Dec 23;183(7):1901-1912.e9
pubmed: 33248470
Clin Infect Dis. 2021 Sep 15;73(6):e1397-e1401
pubmed: 33949644
Nat Commun. 2021 Mar 26;12(1):1931
pubmed: 33771993
Clin Chem. 2021 Dec 30;68(1):16-18
pubmed: 34314495
J Clin Microbiol. 2021 Oct 19;59(11):e0046921
pubmed: 34346713
N Engl J Med. 2021 Aug 5;385(6):562-566
pubmed: 34347959